Developments in gastrointestinal tumour treatment

Towards deciphering the functional genetics and neo-antigenic landscape in melanoma

Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?

Polycomb repressors and epigenetic therapy

DNA repair and mutations as targets for personalised therapy

The changing process of drug discovery and design

Targeting and imaging invasion and metastasis

ERß expression predicts breast cancer risk in hyperplasia

Polygenic risk and the targeted prevention of cancer

Regulation of T cells in tissues and tumours

ß1 integrins and DNA repair for radiosensitization of head and neck cancer

Understanding mutational processes in human cancer